This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
Save the dateMarch 17–19, 2025 | Milan, Italy

Michelle Chen
CBO at Insilico Medicine


Michelle Chen is the Chief Business Officer of Insilico Medicine, a global leader in generative AI-driven drug discovery & development. She is responsible for the company’s business and corporate development, portfolio strategies, marketing, and US operations.

As a biotech executive, Michelle brings in 20+ years of experience in the biopharma and life sciences industries, having worked at multi-national companies such as Roche, Merck, BioMarin, Agilent, as well as small biotech companies. She has a strong track record of success in company building, BD&L, M&A, R&D, marketing, and product commercialization.

Michelle has a Ph.D. in Biochemistry from the University of Washington, did her postdoctoral work at UCSF, and received Bioinformatics training at Stanford.

Agenda Sessions

  • Meet the dealmakers in oncology: Insilico Medicine and Menarini